Needham analyst David Saxon reiterated a Buy rating on CryoPort (CYRX – Research Report) today and set a price target of $41.00. The company’s shares closed last Thursday at $24.17, close to its 52-week low of $21.61.
According to TipRanks.com, Saxon ‘s ranking currently consits of 0 on a 0-5 ranking scale, with an average return of -9.7% and a 19.3% success rate. Saxon covers the Healthcare sector, focusing on stocks such as Irhythm Technologies, Alphatec Holdings, and Globus Medical.
The word on The Street in general, suggests a Strong Buy analyst consensus rating for CryoPort with a $56.33 average price target, representing a 122.6% upside. In a report issued on May 2, SVB Securities also maintained a Buy rating on the stock with a $45.00 price target.
See Insiders’ Hot Stocks on TipRanks >>
CryoPort’s market cap is currently $1.2B and has a P/E ratio of -4.07.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
CryoPort, Inc. engages in the provision of logistics solutions to the life science industry. It also provides logistics solutions for biologic materials such as immunotherapies, stem cells, CAR-T cells, and reproductive cells for clients worldwide, including points-of-care, clinical research organizations central laboratories, biopharmaceuticals, contract manufacturing, health centers, and university researchers. It offers personalized medicine, immunotherapies, cellular therapies, CAR T-cell therapies, stem cell therapies, cell lines, vaccines, diagnostic materials, semen, eggs, embryos, cord blood, bio-pharmaceuticals, infectious substances, and other commodities that require continuous exposure to certain ranges of precision-controlled temperatures. The company was founded on May 25, 1990 and is headquartered in Irvine, CA.
Read More on CYRX:
- Chardan Capital Reiterates a Buy Rating on ProQR (PRQR)
- Swiss Re AG (SSREF) Receives a Hold from Deutsche Bank
- Chesapeake Utilities (CPK) Gets a Buy Rating from Maxim Group
- Analysts Conflicted on These Technology Names: Synaptics (SYNA) and Bandwidth (BAND)
- Maxim Group Thinks Turtle Beach’s Stock is Going to Recover
